SS-31: ATP for Thyroid Function

Learn how SS-31 (Elamipretide), a mitochondria-targeted peptide, supports thyroid function by optimizing ATP production at the cellular level.

SS-31ThyroidPublished: January 30, 2026

Introduction

Thyroid hormones tell your cells to produce energy. But cells cannot produce energy without the machinery to do so -- and that machinery is the mitochondria. When mitochondrial function is compromised, even optimal thyroid signaling cannot produce optimal energy output.

SS-31 (Elamipretide) is a mitochondria-targeted tetrapeptide that concentrates 1000-5000x within mitochondria to stabilize the electron transport chain and optimize ATP production. It represents one of the most targeted approaches to improving cellular energy production at its source.

In this article, you will explore how SS-31 supports the cellular machinery that thyroid hormones depend on, why ATP production matters for metabolic function, and how FixMyT can help you understand whether mitochondrial energy may be limiting your thyroid function. If fatigue and low energy have persisted despite "normal" thyroid labs, this connection is worth understanding.

Understanding the Thyroid: The Rate of Your Metabolism

The Thyroid node in the FixMyT metabolic tree occupies Level 2, downstream from Mitochondria and the Liver. Its subtitle "Rate" captures its function: setting the speed of your entire metabolism. But this rate can only be expressed if the cellular machinery can keep up.

The Thyroid node encompasses:

  • Metabolic rate: How fast you burn fuel
  • Warmth: Body heat generation
  • Pulse: Heart rate support
  • Digestion support: Gut motility

When thyroid symptoms persist despite adequate thyroid hormone levels, the problem may be downstream at the mitochondrial level. Thyroid hormones work by:

  1. Entering cells
  2. Binding to nuclear receptors
  3. Upregulating genes for mitochondrial activity
  4. Stimulating mitochondria to produce more ATP

If mitochondria are dysfunctional -- damaged membranes, inefficient electron transport, excessive oxidative stress -- they cannot respond to the thyroid signal. SS-31 addresses this by optimizing mitochondrial function directly.

What Is SS-31?

SS-31 (also known as Elamipretide, Bendavia, or MTP-131) is a synthetic tetrapeptide developed by Drs. Hazel Szeto and Peter Schiller. It was rationally designed to concentrate within the inner mitochondrial membrane and stabilize cardiolipin, a phospholipid essential for electron transport chain function.

Key characteristics:

  • Sequence: D-Arg-Dmt-Lys-Phe-NH2 (Dmt = 2',6'-dimethyltyrosine)
  • Molecular weight: 640.77 g/mol
  • Unique feature: Concentrates 1000-5000x within mitochondria
  • Mechanism: Cardiolipin stabilization
  • Clinical status: Phase 3 for Barth syndrome; FDA Fast Track and Orphan Drug designations

Unlike general antioxidants that scavenge free radicals after they form, SS-31 reduces oxidative stress at its source by improving electron transport efficiency and reducing electron leak.

For complete technical details, see the full SS-31 profile on PepGuide.

How SS-31 Supports Thyroid Function

SS-31's relevance to thyroid function comes through its effects on mitochondrial ATP production.

1. Cardiolipin Stabilization

Cardiolipin is a phospholipid unique to the inner mitochondrial membrane. It is essential for:

  • Proper assembly of electron transport chain complexes
  • Efficient electron flow through the chain
  • ATP synthase function
  • Maintaining cristae structure

SS-31 binds directly to cardiolipin, stabilizing its interactions with ETC complexes. This is particularly relevant because thyroid hormones increase mitochondrial activity -- if cardiolipin is damaged or oxidized, mitochondria cannot respond to thyroid signaling.

2. ATP Production Optimization

The electron transport chain converts nutrients into ATP through oxidative phosphorylation. SS-31 improves this process by:

  • Reducing electron leak at Complexes I and III
  • Improving coupling efficiency
  • Restoring membrane potential in damaged mitochondria
  • Enhancing overall ATP production capacity

For thyroid function, more efficient ATP production means the cells can actually express the metabolic rate that thyroid hormones are signaling for.

3. ROS Reduction at Source

Mitochondrial dysfunction leads to excessive reactive oxygen species (ROS) production, which causes further mitochondrial damage in a vicious cycle. SS-31 breaks this cycle by:

  • Reducing electron leak that generates ROS
  • Preserving cardiolipin from oxidative damage
  • Normalizing rather than eliminating ROS (some ROS are needed for signaling)

4. Age-Related Mitochondrial Decline

Both thyroid function and mitochondrial function decline with age. SS-31 has shown remarkable effects in aged animals:

  • Improved cardiac function to levels comparable to young adults
  • Enhanced skeletal muscle mitochondrial function
  • Reduced age-related increase in mitochondrial ROS
  • Improved exercise capacity

This suggests potential for addressing age-related metabolic decline at the mitochondrial level.

5. Clinical Evidence for Mitochondrial Disease

SS-31 has Phase 3 data in Barth syndrome, a genetic mitochondrial disorder. While not directly a thyroid condition, this demonstrates:

  • Ability to improve mitochondrial function in humans
  • Measurable functional improvements
  • Acceptable safety profile
  • Potential for broader mitochondrial applications

What Real People Are Saying

SS-31 is discussed in longevity and mitochondrial health communities:

"Started SS-31 after years of fatigue that no amount of thyroid medication helped. The improvement in energy was noticeable within 2 weeks. My theory is my thyroid was fine, but my mitochondria couldn't keep up with the signal." — u/mitochondria_first on r/Peptides

"Using SS-31 as part of a mitochondrial optimization stack. Body temperature came up, cold tolerance improved, energy is more consistent. These are typically 'thyroid' symptoms but my thyroid was always normal. The downstream machinery matters." — u/mito_stack on r/Longevity

"The cardiolipin mechanism is fascinating. As we age, cardiolipin gets oxidized and damaged. SS-31 stabilizes it. This could explain why thyroid function seems to decline with age even when hormone levels are maintained -- the cellular response machinery degrades." — u/cardiolipin_researcher on r/Biohacking

These are individual experiences. SS-31 is still investigational in the US.

Monitoring Your Thyroid Health with FixMyT

Understanding the thyroid-mitochondria connection requires looking at both nodes. FixMyT provides a systematic framework.

The FixMyT symptoms quiz identifies markers for both:

Thyroid symptoms:

  • Cold hands/feet
  • Low body temperature
  • Slow pulse
  • Constipation
  • Hair loss

Mitochondrial symptoms:

  • Chronic fatigue
  • Poor exercise recovery
  • Cold intolerance

The visual metabolic tree shows Mitochondria upstream of Thyroid. This positioning reflects biological reality: mitochondrial function affects how cells respond to thyroid signaling. Addressing Mitochondria may improve Thyroid output downstream.

Research and Considerations

SS-31 has one of the most robust evidence bases for a mitochondria-targeted peptide:

What the evidence supports:

  • Cardiolipin binding and stabilization (well-characterized)
  • ATP production improvement in multiple tissue types
  • Functional improvements in Phase 3 Barth syndrome trials
  • FDA Fast Track and Orphan Drug designations

What needs more research:

  • Direct effects on thyroid parameters
  • Applications beyond primary mitochondrial disease
  • Long-term safety data
  • Optimal dosing for metabolic optimization

Important considerations:

  • Research-grade SS-31 may differ from pharmaceutical-grade used in trials
  • Partial renal clearance means caution in kidney impairment
  • Not yet FDA-approved
  • Clinical development ongoing

Disclaimer

This article is for educational and research purposes only. SS-31 (Elamipretide) is an investigational drug with FDA Fast Track designation but is not yet approved. Nothing in this article constitutes medical advice or a recommendation to use any substance.

Thyroid and mitochondrial conditions require proper medical evaluation. If you are experiencing symptoms of low metabolic rate or chronic fatigue, consult with an appropriate specialist.

Individual responses vary significantly. The information here reflects current research as of the publication date.

Learn More

References

  1. Szeto HH. "First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics." British Journal of Pharmacology. 2014;171(8):2029-2050. doi:10.1111/bph.12461

  2. Birk AV, Liu S, Soong Y, et al. "The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin." Journal of the American Society of Nephrology. 2013;24(8):1250-1261.

  3. Reid Thompson W, Hornby B, Manuel R, et al. "A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome." Genetics in Medicine. 2021;23(3):471-478.

  4. Siegel MP, Kruse SE, Percival JM, et al. "Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice." Aging Cell. 2013;12(5):763-771.

  5. Mullur R, Liu YY, Brent GA. "Thyroid hormone regulation of metabolism." Physiological Reviews. 2014;94(2):355-382.

Tags

thyroidss-31metabolic healthpeptide researchmitochondriaatp

Understand Your Metabolic Health

Take our free assessment to discover which metabolic nodes need attention.

Take the Quiz